CO6491037A2 - Derivados de pirazinooxazepina - Google Patents

Derivados de pirazinooxazepina

Info

Publication number
CO6491037A2
CO6491037A2 CO12004620A CO12004620A CO6491037A2 CO 6491037 A2 CO6491037 A2 CO 6491037A2 CO 12004620 A CO12004620 A CO 12004620A CO 12004620 A CO12004620 A CO 12004620A CO 6491037 A2 CO6491037 A2 CO 6491037A2
Authority
CO
Colombia
Prior art keywords
pirazinooxazepina
derivatives
compound
kt2c
serotonin
Prior art date
Application number
CO12004620A
Other languages
English (en)
Inventor
Shigekasu Sasaki
Tomokazu Kusumoto
Izumi Nomura
Hironobu Maezaki
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CO6491037A2 publication Critical patent/CO6491037A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se proporciona un compuesto que tiene una acción activadora del receptor de 5-KT2c de serotonina.Un compuesto representado por la fórmula (l0):en donde cada símbolo es como se definió en la memoria descriptiva o una de sus sales.
CO12004620A 2009-06-15 2012-01-13 Derivados de pirazinooxazepina CO6491037A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009142673 2009-06-15

Publications (1)

Publication Number Publication Date
CO6491037A2 true CO6491037A2 (es) 2012-07-31

Family

ID=42561089

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12004620A CO6491037A2 (es) 2009-06-15 2012-01-13 Derivados de pirazinooxazepina

Country Status (41)

Country Link
US (4) US8318722B2 (es)
EP (1) EP2442870B1 (es)
JP (2) JP5579262B2 (es)
KR (1) KR101768234B1 (es)
CN (1) CN102458579B (es)
AR (1) AR077094A1 (es)
AU (1) AU2010260847B2 (es)
BR (1) BRPI1011502A2 (es)
CA (1) CA2765239C (es)
CL (1) CL2011003154A1 (es)
CO (1) CO6491037A2 (es)
CR (1) CR20120021A (es)
CY (1) CY1115483T1 (es)
DK (1) DK2442870T3 (es)
DO (1) DOP2011000393A (es)
EA (1) EA021079B1 (es)
EC (1) ECSP12011603A (es)
ES (1) ES2480275T3 (es)
GE (1) GEP20146168B (es)
HK (1) HK1169623A1 (es)
HR (1) HRP20140589T1 (es)
IL (1) IL216761A (es)
JO (1) JO3087B1 (es)
MA (1) MA33430B1 (es)
ME (1) ME01835B (es)
MX (1) MX2011013081A (es)
MY (1) MY157497A (es)
NZ (1) NZ597507A (es)
PE (1) PE20121049A1 (es)
PL (1) PL2442870T3 (es)
PT (1) PT2442870E (es)
RS (1) RS53414B (es)
SG (1) SG176696A1 (es)
SI (1) SI2442870T1 (es)
SM (1) SMT201400080B (es)
TN (1) TN2011000630A1 (es)
TW (2) TWI542592B (es)
UA (1) UA108357C2 (es)
UY (1) UY32707A (es)
WO (1) WO2010147226A1 (es)
ZA (1) ZA201109370B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2742936A1 (en) * 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
PL2442870T3 (pl) * 2009-06-15 2014-12-31 Takeda Pharmaceuticals Co Pochodne pirazynooksazepiny
US20130267500A1 (en) 2010-09-01 2013-10-10 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
JP2014201578A (ja) * 2013-04-09 2014-10-27 武田薬品工業株式会社 線維筋痛症治療剤
JP2014214132A (ja) * 2013-04-26 2014-11-17 武田薬品工業株式会社 ニコチン依存症の予防・治療剤
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use
WO2017026538A1 (en) 2015-08-07 2017-02-16 Takeda Pharmaceutical Company Limited Production method of pyrazine
TW201729814A (zh) 2015-12-24 2017-09-01 武田藥品工業股份有限公司 固形製劑
US9985579B2 (en) 2016-04-12 2018-05-29 Preformed Line Products Co. Mounting assembly for mounting a solar panel
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2992677B2 (ja) 1995-06-05 1999-12-20 武田薬品工業株式会社 骨形成促進医薬組成物
SE0002754D0 (sv) 2000-07-21 2000-07-21 Pharmacia & Upjohn Ab New pharmaceutical combination formulation and method of treatment with the combination
CA2428905A1 (en) 2000-11-20 2002-05-23 Biovitrum Ab PIPERAZINYLPYRAZINE COMPOUNDS FOR USE AS ANTAGONISTS OF THE SEROTONIN 5-HT2 RECEPTOR
AU2002314744A1 (en) 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
SE0201544D0 (sv) 2002-05-17 2002-05-17 Biovitrum Ab Novel compounds and thier use
CA2485532C (en) 2002-06-19 2012-03-06 Biovitrum Ab Process for the preparation of 2-methyl piperazine derivatives
WO2004000830A1 (en) 2002-06-19 2003-12-31 Biovitrum Ab Novel compounds, their use and preparation
CA2514547A1 (en) 2003-01-28 2004-08-12 Takeda Pharmaceutical Company Limited Receptor agonists
CL2004000826A1 (es) 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
CN101792417A (zh) 2003-06-17 2010-08-04 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
EP2189448B1 (en) 2003-06-17 2014-01-29 Arena Pharmaceuticals, Inc. Processes for the Separation of 3-Benzazepine Racemates
JP2006056881A (ja) 2004-07-21 2006-03-02 Takeda Chem Ind Ltd 縮合環化合物
US8420631B2 (en) 2005-09-01 2013-04-16 Eli Lilly And Company 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
FR2895259B1 (fr) 2005-12-22 2008-02-22 Urosphere Sas Methodes de traitement des incontinences urinaires
EP2742936A1 (en) * 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
WO2008108445A1 (ja) * 2007-03-07 2008-09-12 Takeda Pharmaceutical Company Limited ベンゾオキサゼピン誘導体およびその用途
WO2009032754A2 (en) 2007-08-31 2009-03-12 Kalypsys, Inc. Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease
WO2009063993A1 (ja) * 2007-11-15 2009-05-22 Takeda Pharmaceutical Company Limited 縮合ピリジン誘導体およびその用途
EP2213675B1 (en) * 2007-11-15 2013-08-14 Takeda Pharmaceutical Company Limited Pyridooxazepine derivative and use thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
PL2442870T3 (pl) * 2009-06-15 2014-12-31 Takeda Pharmaceuticals Co Pochodne pirazynooksazepiny
US8299103B2 (en) 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor

Also Published As

Publication number Publication date
EP2442870A1 (en) 2012-04-25
MY157497A (en) 2016-06-15
US9115139B2 (en) 2015-08-25
US20110282054A1 (en) 2011-11-17
HRP20140589T1 (hr) 2014-08-01
AU2010260847B2 (en) 2016-11-24
KR101768234B1 (ko) 2017-08-14
CR20120021A (es) 2012-03-06
UY32707A (es) 2011-01-31
AU2010260847A1 (en) 2012-01-19
HK1169623A1 (en) 2013-02-01
DOP2011000393A (es) 2012-02-15
US20100317651A1 (en) 2010-12-16
JP5579262B2 (ja) 2014-08-27
IL216761A0 (en) 2012-02-29
US8314088B2 (en) 2012-11-20
US8324201B2 (en) 2012-12-04
CN102458579B (zh) 2014-11-05
EP2442870B1 (en) 2014-04-16
DK2442870T3 (da) 2014-06-30
AR077094A1 (es) 2011-08-03
PT2442870E (pt) 2014-07-16
EA201270017A1 (ru) 2012-07-30
CA2765239C (en) 2018-08-07
GEP20146168B (en) 2014-09-25
JP2012107032A (ja) 2012-06-07
MX2011013081A (es) 2012-01-20
TW201529584A (zh) 2015-08-01
CL2011003154A1 (es) 2012-06-15
ES2480275T3 (es) 2014-07-25
CY1115483T1 (el) 2017-01-04
ZA201109370B (en) 2012-10-31
TW201109338A (en) 2011-03-16
MA33430B1 (fr) 2012-07-03
JO3087B1 (ar) 2017-03-15
TWI542592B (zh) 2016-07-21
KR20120034734A (ko) 2012-04-12
JP2012530051A (ja) 2012-11-29
US20120135979A1 (en) 2012-05-31
SMT201400080B (it) 2014-09-08
JP5579203B2 (ja) 2014-08-27
TN2011000630A1 (en) 2013-05-24
CN102458579A (zh) 2012-05-16
IL216761A (en) 2016-03-31
PL2442870T3 (pl) 2014-12-31
US20110288291A1 (en) 2011-11-24
RS53414B (en) 2014-12-31
ECSP12011603A (es) 2012-03-30
SI2442870T1 (sl) 2014-07-31
NZ597507A (en) 2013-09-27
PE20121049A1 (es) 2012-08-22
SG176696A1 (en) 2012-01-30
CA2765239A1 (en) 2010-12-23
ME01835B (me) 2014-12-20
UA108357C2 (xx) 2015-04-27
EA021079B1 (ru) 2015-03-31
WO2010147226A1 (en) 2010-12-23
BRPI1011502A2 (pt) 2016-03-22
US8318722B2 (en) 2012-11-27

Similar Documents

Publication Publication Date Title
CO6491037A2 (es) Derivados de pirazinooxazepina
CR20150509A (es) Derivados de naftiridina utiles como antagonistas de la alfa-v-beta-6 integrina
CR20130066A (es) Compuesto heterocíclico y su uso
UY36199A (es) Compuesto heterocíclico
DOP2010000267A (es) Compuesto heterociclico
DOP2016000206A (es) Compuesto heterocíclico fusionado
UY34336A (es) Derivados 5-fluoro pirimidina disustituidos que contienen un grupo sulfoximina
CR20140525A (es) Compuestos de N-alquiltriazol como antagonistas de LPAR
DOP2010000053A (es) Derivados de pirrolidin -2-ona como moduladores del receptor de androgeno
CR20160368A (es) Compuesto heterocíclico
DOP2013000188A (es) Metodo de produccion de derivado de dihidrobenzofurano opticamente activo
CR20110581A (es) Preparación de solido
CR20110463A (es) Compuesto de anillo fusionado y su uso
CO6260091A2 (es) Derivados de iminopiridina y su uso
DOP2013000051A (es) Compuestos heterociclico y sus usos
CL2017000069A1 (es) Derivado de hidantoina.
CO6470817A2 (es) Cristales de solvato novedosos
ECSP13012593A (es) Derivados de 1,4-oxazepano
UY34072A (es) Derivados sustituidos de indol
BR112015028751A2 (pt) processo para a preparação de derivados de 3,5-bis (fluoralquil)pirazol a partir de alfa,alfa-dihaloaminas
UY32088A (es) Compuesto heterociclico
UY32191A (es) Derivados de iminopiridina y uso de los mismos
ES2722073T3 (es) Conjugados azúcar-dipéptido como moléculas saborizantes
UY33560A (es) Compuestos heterociclicos
TR201205911U (tr) Dikkat çekici bebek önlüğü.

Legal Events

Date Code Title Description
FG Application granted